How to Structure Private Equity AI Investment Business Cases

Last reviewed: August 2026.

A private equity firm evaluating an AI investment inside a portfolio company, or underwriting an AI-driven value-creation thesis ahead of an acquisition, needs a different business case than a single company evaluating AI for its own operations. The audience is an investment committee, not just an executive team, and the case has to survive the same scrutiny as any other capital allocation decision: a return bridge to MOIC and IRR, a realistic hold-period timeline, a defensible cost model, and evidence that will hold up when a future buyer's diligence team pulls it apart.

Quick answer: A PE-grade AI business case starts by underwriting operational value, revenue, gross margin, operating cost, and cash flow, on its own, before any exit-multiple assumption. It discounts theoretical opportunity for technical feasibility, adoption, and realization capture rather than treating identified savings as captured value. It models one-time and recurring AI costs against a benefit ramp timed to the remaining hold period, separates value captured during ownership from residual value a future buyer might recognize at exit, and includes a downside case, stage gates, and kill criteria rather than one deterministic forecast. Only after the operational case works on its own should exit-multiple uplift enter the model, as a sensitivity, not the primary justification.

How a PE AI Business Case Differs From a Corporate AI ROI Case

A corporate AI business case may focus primarily on operational ROI and strategic value within an ongoing business. A PE-oriented case adds another layer: the initiative has to be evaluated against sponsor return objectives, the remaining ownership period, and what can credibly be evidenced and valued at exit, because the reader isn't just approving a project, they're deciding whether a specific initiative changes the return profile of an investment with a defined ownership window. That means connecting AI's operational impact through an actual equity-return bridge, timing it against the years actually remaining in the hold, building evidence that survives a future buyer's diligence, and deciding whether the approach is repeatable across other portfolio companies without assuming the economics transfer along with it. See our enterprise business case guide for C-suite AI adoption for the corporate-side version of this exercise.

The Qubify PE AI Value Bridge

Structure the case as a single chain from operational opportunity to equity value, so every number in the case can be traced back to where it actually came from:

Operational opportunity → realization-adjusted realizable benefit → net EBITDA impact → cash-flow impact → hold-period value captured → residual value at exit

Each link matters. A business case that jumps straight from "operational opportunity" to "exit value" is the pattern an investment committee should push back on, since it skips the realization discount, the cost model, and the timing question entirely.

Start With the Investment Thesis and AI Disruption Risk

Before modeling a specific initiative, classify what role AI actually plays in the investment thesis. Bain's research on AI diligence describes buyers now examining AI as both an opportunity and a threat, assessing whether AI could disrupt a target's business model, change pricing and market volumes, erode a competitive moat, or otherwise shift target attractiveness in ways that go beyond a single efficiency project.

Some AI spending is defensive value preservation rather than incremental EBITDA creation. That's a legitimate rationale, but it belongs in the case explicitly, not folded into an efficiency narrative it doesn't actually fit.

Establish the Operating Baseline

Every number that follows depends on a clean starting point: current cost base for the function AI will touch, current cycle time or throughput, current headcount and contractor spend, current revenue and conversion metrics tied to the process, and the seasonality or demand pattern that could otherwise be mistaken for AI-driven improvement later. Capture this before implementation begins, since a baseline built retroactively is far weaker evidence in diligence than one documented in advance.

Separate Productivity From Realized EBITDA

This is the distinction most AI business cases get wrong. If a task drops from ten hours to six, that's freed capacity, not automatically a 40% labor saving. The company might use the freed time to handle more volume, improve service, absorb growth without new hires, reduce contractor spend, eliminate a position, or simply do nothing with it. Only some of those outcomes actually move EBITDA.

Every line in the business case should state explicitly which column it lives in. "Capacity created" is a real result and worth tracking, but it isn't a number that belongs in an EBITDA bridge until something converts it into cost removed or revenue captured.

The Qubify AI Value Realization Formula

Theoretical opportunity is not the number to underwrite. Discount it by how much of it actually gets captured:

Realization-adjusted annual value = gross opportunity × technically addressable share × adoption share × economic realization share

Treat these three factors as sequential capture ratios, each with its own denominator, rather than three independent discounts on the same gross number: the technically addressable share is the portion of the gross opportunity that's technically feasible at all; the adoption share is the portion of that technically feasible scope that people actually use; and the economic realization share is the portion of the adopted scope that actually converts into a measured operational or financial result rather than unused capacity. Measuring adoption against the feasible scope, and realization against the adopted scope, keeps the three factors from double-discounting the same underlying risk. This is a planning decomposition, not a statistically validated expected-value model; if probabilities of implementation failure or other scenario outcomes are modeled separately elsewhere in the case, don't apply them again through these capture ratios unless they represent a genuinely distinct risk. As an illustrative calculation only, not a benchmark: a theoretical gross saving of $2.0M, discounted by a 90% technically addressable share, 80% adoption of the feasible scope, and 70% realization of the adopted scope, produces $2.0M × 0.90 × 0.80 × 0.70 ≈ $1.008M in realization-adjusted annual value. Every percentage in that calculation is deal-specific and needs its own justification, not a default assumption.

Model One-Time and Recurring AI Costs

The business case needs a real cost line, not a placeholder. One-time costs typically include discovery and process redesign, data cleanup, systems integration, implementation and configuration, model evaluation, security review, change management, employee training, and legal or compliance assessment; see our AI agent development cost guide for how these break down for a custom build. Recurring costs typically include model or API usage, inference infrastructure, licensing, observability and evaluation tooling, human review capacity, ongoing maintenance, security, vendor support fees, and periodic retraining or re-evaluation; see our hidden AI infrastructure maintenance costs guide for the recurring costs that get missed most often. Net these against the realization-adjusted gross benefit before calling anything an EBITDA impact: gross AI benefit minus recurring run cost equals net run-rate benefit, and only the net figure belongs in the return bridge.

Build the EBITDA, Cash-Flow, and Equity-Value Bridges

This is where operational impact actually enters the equity-return calculation, and it has to run through three separate bridges rather than one blended calculation, or costs and revenue get counted more than once.

1. Operating bridge, to incremental EBITDA. Incremental revenue multiplied by its contribution margin, plus gross-profit or COGS savings, plus operating-expense savings, minus recurring AI operating costs and other incremental recurring support or governance costs, equals incremental EBITDA. Enter revenue through the margin it actually earns, not as a separate line alongside gross-margin impact; adding both double-counts the same benefit.

2. Cash-flow bridge, to incremental free cash flow. Incremental EBITDA, minus cash taxes, minus working-capital investment, minus capex or capitalized software, minus one-time implementation and restructuring cash costs, equals incremental free cash flow before financing. This is where the one-time implementation cost from the cost model actually belongs, as a cash item in the period it's spent, not a second deduction against enterprise value later. This is a simplified planning bridge, not a substitute for the portfolio company's full cash-flow model; EBITDA itself isn't cash flow, since it doesn't account for working-capital changes or several other accounting items, so actual cash taxes, depreciation and amortization effects, capitalized-software treatment, and working-capital timing should come from the deal model and the company's finance team.

3. Exit and equity bridge. Apply the exit multiple only to sustainable incremental EBITDA measured on the same basis as the EBITDA used in the transaction valuation; don't apply a full exit multiple to temporary savings, one-time adjustments, or unproven run-rate benefits. Sustainable incremental exit EBITDA multiplied by an assumed exit multiple equals potential enterprise-value uplift; enterprise-value uplift minus incremental net debt at exit, or plus incremental cash, equals potential incremental exit equity value.

Sponsor-return bridge. Incremental free cash flow only becomes a sponsor cash inflow if it's actually distributed. A portfolio company can instead use that cash to repay debt, accumulate it on the balance sheet, or fund another investment, and CFA Institute's private equity curriculum describes exactly this pattern in buyout structures: incremental cash flow used to repay debt over the hold, with the business sold afterward to generate returns. If the cash repays debt or accumulates, its value should appear through lower net debt or higher cash at exit, not as a separate interim distribution counted alongside the exit benefit. Build the sponsor-return case from the actual use of cash: incremental interim distributions, if any, plus incremental exit equity proceeds, minus any additional sponsor equity contributed to fund the initiative. To estimate the initiative's contribution to deal-level MOIC, compare the incremental sponsor proceeds attributable to the initiative with the sponsor equity invested, keeping this separate from a standalone project ROI calculation. To estimate IRR impact, rerun the sponsor-level dated cash-flow schedule with and without the initiative rather than inferring IRR from the operating project's payback period alone.

Don't count the same incremental cash twice. If cash is distributed, count the distribution. If it remains on the balance sheet or repays debt, capture its effect through net debt or cash at exit, not both. Keep run-rate EBITDA, reported or adjusted EBITDA, and cash realization as distinct figures throughout; a business case that blends them, or that lets the same dollar of free cash flow show up as both an interim benefit and a lower-net-debt benefit at exit, will overstate the return.

Model Timing Against the Remaining Hold Period

Value doesn't arrive the day AI goes live. A realistic case models a ramp: an illustrative pattern might run discovery and build in the first few months with no benefit yet realized, a pilot phase capturing a small fraction of steady-state benefit, an adoption-ramp phase capturing a partial but growing share, and a steady-state phase from roughly the second year onward capturing the full realization-adjusted run rate. Applying full-year run-rate benefit starting on day one materially overstates near-term cash flow and understates how long payback actually takes, which matters directly for IRR when the ownership window is finite.

Value Captured During Hold vs. Residual Value at Exit

It's tempting to say an investment that pays back after the expected exit date delivers most of its value to whoever buys the company next. That's directionally useful but too simple. A buyer who capitalizes expected future cash flows, sees lower execution risk from an already-deployed capability, or values a proven platform above an unbuilt roadmap can recognize value in the exit price even before the current sponsor sees full cash payback. BCG's private equity research treats the hold period as a real constraint on AI value realization and a factor in deciding which portfolio companies to prioritize, without treating it as an automatic disqualifier. Separate the case into value captured through EBITDA and cash flow during ownership, and residual value the business case argues a future buyer is likely to recognize at exit, and support that second category with reasoning a buyer would actually find credible, not just an assumption that "the multiple goes up."

Underwrite Zero Multiple Expansion First

For a conservative operating base case, hold the exit multiple constant unless the underwriting includes independent evidence for a different assumption. AI adoption doesn't automatically justify a higher multiple; multiple expansion tends to reflect growth quality, margin durability, recurring revenue strength, competitive position, and buyer sentiment, attributes AI may contribute to but doesn't guarantee. This isn't a universal PE rule, some AI-driven growth narratives can genuinely support a premium valuation, but it's the more defensible starting point. Qubify methodology: underwrite operational value first, and treat multiple expansion as optional upside, modeled separately, unless there's independent evidence that the AI-enabled change improves attributes a future buyer is likely to value on its own. If the case only works with multiple expansion baked in, that's a signal to keep refining the operational model, not to lean harder on the multiple.

Base, Downside, and Upside Scenarios

An investment committee shouldn't receive one deterministic forecast. Model at least three cases, with every value below deal-specific and illustrative only:

From each scenario, carry through the same calculation: payback timing, cumulative cash contribution during the hold, EBITDA uplift, and MOIC/IRR impact. The downside case should be plausible, not engineered to look acceptable. If it implies negative value, payback pushed beyond the hold period, or loss of a material portion of invested capital, show that explicitly and connect it to the stage gates and kill criteria below, rather than softening the downside until it reads as survivable by design.

Worked Example: A Portfolio Company Customer-Service AI Investment

The figures below are illustrative planning inputs to demonstrate the model's mechanics, not published Qubify pricing, universal benchmarks, or a real deal.

Baseline and gross opportunity. Customer-service cost base: $5,000,000/year. Assume process analysis identifies $1,000,000 of that cost base as a theoretical addressable value pool tied to work AI may partially automate or avoid. This is not yet a savings forecast; it's the maximum gross opportunity before feasibility, adoption, realization, and recurring-cost assumptions are applied, consistent with this guide's own productivity-versus-EBITDA distinction.

Realization-adjusted benefit. Applying an 80% technically addressable share, 70% adoption of that scope, and 70% economic realization of the adopted scope: $1,000,000 × 0.80 × 0.70 × 0.70 ≈ $392,000 in realization-adjusted annual gross benefit.

Net run-rate benefit. Recurring AI cost: $100,000/year. Net annual run-rate benefit: $392,000 − $100,000 = $292,000. One-time implementation cost: $350,000.

A naive payback calculation, $350,000 ÷ $292,000, suggests roughly 14 months. That overstates speed, because it assumes full run-rate benefit from day one. Simplifying assumption: the ramp below applies the same realization percentage to the full $292,000 net steady-state benefit, which assumes the $100,000 recurring AI cost already netted into that figure scales roughly in proportion with deployment and adoption. That's often not true in practice: a vendor contract, infrastructure reservation, or support retainer can start costing money before benefits reach full adoption. If recurring costs are fixed, front-loaded, or begin before benefits ramp, model the gross benefit and the recurring cost schedule separately rather than netting them into one ramped figure; payback will differ. Modeling the illustrative ramp on that simplifying assumption:

Under this ramp, cumulative cash position turns positive roughly 23 months in, well past the naive 14-month estimate. Under a three-year remaining hold, that leaves roughly 13 months between modeled cash payback and the assumed exit date. Whether that's attractive depends on the sponsor's return hurdle, execution risk, alternative uses of capital, exit-timing certainty, and any residual value recognized at exit, not on the hold length alone; for a company much closer to exit, the same initiative may be materially harder to justify. Alongside this, the base case above should be tested with zero exit-multiple uplift before any residual exit value is added.

The Qubify PE AI Prioritization Matrix

With a multi-company portfolio, AI investment shouldn't roll out everywhere at once. BCG's PE research specifically recommends prioritizing portfolio companies by hold period, opportunity size, and position before scaling an initiative across the portfolio. This is a planning framework for comparing candidate companies against the same drivers, not a validated scoring model with fixed weights; use it to structure the discussion, not to produce a single number the committee treats as precise:

Stage-Gate the Investment Instead of Committing Capital Upfront

Fund the initiative in stages, unlocking each one only when the evidence from the prior stage clears the bar, rather than approving a full multi-year budget on a single upfront thesis:

1. Stage 0: thesis. The investment rationale, baseline, and target use case are defined.
2. Stage 1: feasibility. Technical feasibility is validated against real company data and systems.
3. Stage 2: controlled pilot. A limited rollout produces real, measured results, not a demo.
4. Stage 3: measured adoption. Usage and captured value are tracked against the baseline at meaningful scale.
5. Stage 4: scale. The initiative rolls out company-wide with continued measurement.
6. Stage 5: portfolio replication. The validated architecture is evaluated for reuse elsewhere in the portfolio.

This manages uncertainty better than a single upfront capital commitment, since it forces the case to keep proving itself against real evidence rather than the original forecast.

Define Kill Criteria

Every IC case should define not just what success looks like, but when to stop. Example deal-specific kill criteria can include: adoption falling below a defined threshold, unit economics failing to clear the net-benefit bar, accuracy or reliability falling below a minimum operating threshold, integration cost exceeding a defined ceiling, a timeline that pushes value realization beyond the relevant ownership window, a risk or compliance issue that can't be adequately mitigated, vendor economics deteriorating materially, or the business proving unable to actually capture the theoretical productivity gain in practice. Set these before funding stage 1, not after the initiative is already underperforming.

Build the AI Exit Evidence Pack

KPMG's private equity value-creation research emphasizes aligning measurement to the value-creation plan and demonstrating tangible operational improvement, not simply documenting that technology was deployed. For exit diligence, document: the baseline period and how it was defined, the metric definition itself, the implementation date, the adoption rate and user population, a pre/post comparison that accounts for seasonality, a control or comparison group where one is available, gross versus net savings, realized results versus run-rate projections, recurring AI costs, any headcount redeployment or removal, the effect on revenue or customer metrics, system reliability, data and security governance, IP ownership, and vendor dependencies. Assembled together, this becomes the evidence a future buyer's diligence team actually needs to underwrite the improvement as real. See our enterprise AI SLA benchmarks guide for how to define the reliability commitments a buyer will expect this evidence to hold up against in production.

Attribution deserves its own discipline here. In practice, clean causal attribution is often impossible when pricing changes, headcount changes, process redesign, demand shifts, or other automation happen at the same time as the AI initiative. Define an attribution methodology before implementation begins. Where clean causal attribution isn't achievable, document the baseline, the concurrent changes, the assumptions made, and the evidence supporting the portion of observed improvement reasonably associated with the AI initiative, rather than presenting the entire change as AI-created value.

Portfolio-Wide Repeatability: Reuse the Playbook, Re-underwrite the Economics

Bain's research on generative AI in private equity describes firms building shared capabilities, from centers of excellence running regular workshops to structured programs for transferring lessons across portfolio companies, and treating that organizational capability itself as a value-creation lever. That's a real advantage, but "it worked at Company A" doesn't mean "the same ROI applies at Companies B, C, and D." Separate what's actually reusable:

Reusable architecture: the evaluation framework, integration patterns, governance model, prompts or agent designs, vendor contracts, and implementation templates.

Company-specific economics: wage base, transaction volume, existing systems, data readiness, adoption conditions, regulatory constraints, and customer mix.

Standardize the implementation playbook. Re-underwrite the economics for every portfolio company, since the numbers in this guide's worked example won't transfer unchanged to a company with a different cost base or adoption profile. See our custom vs. packaged SaaS ROI guide for how build-versus-buy decisions affect how much of that architecture is actually portable across portfolio companies running different existing systems.

IC One-Page Business Case Template

Questions the IC Should Require Before Approving Capital

1. What is the current baseline, and how was it measured?
2. What operational KPI actually changes?
3. How does that KPI translate into a financial number?
4. What portion is theoretical capacity versus cash-realizable benefit?
5. What are the one-time implementation costs?
6. What are the recurring AI costs?
7. What feasibility, adoption, and realization assumptions drive the realization-adjusted benefit?
8. When does the benefit actually begin, and what does the ramp look like?
9. How much of the expected hold period remains?
10. What is payback, modeled against the ramp rather than a naive calculation?
11. What is the cumulative cash impact by the expected exit date?
12. Does the base case work with zero exit-multiple expansion?
13. What is the downside case's IRR and MOIC impact?
14. What AI disruption risk exists if the company does nothing?
15. What evidence will prove the value is real at exit?
16. Who owns delivery?
17. What are the stage gates?
18. What are the kill criteria?
19. What parts of this initiative can be reused elsewhere in the portfolio?
20. What has to be re-underwritten company by company?

Frequently Asked Questions

How is a PE-oriented AI business case different from a standard corporate one?

It has to carry the operational impact all the way through to an equity-return bridge, MOIC and IRR, not just an internal ROI metric, and it has to be timed against a specific, finite hold period rather than an open-ended payback assumption.

Should the business case assume AI adoption expands the exit multiple?

No, not by default. Underwrite the operational case, revenue, margin, cost, and cash flow, so it works with zero multiple expansion first. Treat any exit-multiple benefit as a separate sensitivity, supported by a specific reason a future buyer would pay more, not an assumption that follows automatically from adopting AI.

Why does the hold period matter for AI investment decisions?

A benefit ramp that completes well after the expected exit date shifts more of the realized value to a future buyer than the current sponsor. That said, full cash payback before exit isn't the only test; a buyer may still recognize residual value in an already-deployed, lower-risk capability. Model both value captured during the hold and residual value expected at exit, separately.

Is freed-up employee capacity the same as an EBITDA improvement?

No. Capacity only becomes EBITDA once it's converted into an actual cost removed or revenue captured, through avoided hiring, reduced contractor spend, headcount reduction, or increased conversion. Until that conversion happens, it's a real operational result, but it doesn't belong in the EBITDA bridge yet.

How do I make AI value creation defensible in future due diligence?

Define an attribution methodology and document the baseline before implementation starts, then track adoption, realized results, concurrent changes, and recurring costs with enough rigor that a future buyer's diligence process can distinguish AI-attributable improvement from other factors moving at the same time.

Does a single portfolio-company AI implementation make a strong investment thesis?

It's a reasonable starting point, but a validated, repeatable implementation architecture, evaluation framework, integration pattern, governance model, applied across multiple portfolio companies makes a stronger thesis. The economics still need to be re-underwritten for each company; wage base, volume, and adoption conditions differ even when the architecture doesn't.

Why use stage gates instead of approving the full budget upfront?

Funding in stages, thesis, feasibility, pilot, adoption, scale, portfolio replication, ties each capital release to evidence from the prior stage, which manages uncertainty better than committing a multi-year budget against a single unproven forecast.

What belongs in an AI exit evidence pack?

A documented baseline and metric definition, implementation date, adoption rate, a pre/post comparison that accounts for seasonality, gross versus net savings, realized versus run-rate results, recurring costs, any headcount effect, and an explicit attribution methodology for isolating AI's contribution from concurrent changes.

Methodology and sources: This guide draws on BCG's private equity AI value-creation research on prioritizing portfolio companies by hold period and opportunity, embedding AI into value-creation and 100-day plans, and tracking adoption, ROI, and financial outcomes; Bain's research on generative AI in private equity, including how firms experiment with use cases before scaling and build shared capabilities across portfolio companies; Bain's research on AI diligence, covering how buyers assess AI as both a value-creation opportunity and a disruption risk to a target's business model, pricing, and competitive position; and KPMG's private equity value-creation research on aligning AI measurement to the value-creation plan. The sponsor-return and enterprise-value mechanics draw on CFA Institute's private equity curriculum on how buyout returns depend on entry and exit equity values and the use of interim cash flow to repay debt, and CFA Institute's enterprise-value-multiples curriculum on the distinction between EBITDA and cash flow. Every dollar figure, percentage, and timeline in this guide's formulas and worked example is illustrative only, not a published benchmark; underwrite each portfolio company's numbers against its own baseline, cost structure, and hold period.

Our team helps structure AI investment cases around the return bridge, evidence, and hold-period economics your investment committee actually needs to see, not a generic corporate ROI template.